Home/Liberate Bio/Shawn Davis, PhD
SD

Shawn Davis, PhD

CEO

Liberate Bio

Therapeutic Areas

Liberate Bio Pipeline

DrugIndicationPhase
In Vivo CAR-M ProgramB-cell driven autoimmune diseases / Hematologic cancersPreclinical